Treatment Of Skin Injuries Associated With Auto-Immune And Inflammatory Diseases Using The Arsenic Compound As2O5

Patent No. EP2988757 (titled "Treatment Of Skin Injuries Associated With Auto-Immune And Inflammatory Diseases Using The Arsenic Compound As2O5") was filed by Centre National DE LA Recherche Scientifique Cnrs on Apr 25, 2014. The application was issued on Jan 12, 2022.

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
MEDSENICOct 15, 2019SANTARELLI

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP2988757

CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE CNRS
Application Number
EP14720568A
Filing Date
Apr 25, 2014
Status
Patent Maintained As Amended
Dec 10, 2021
Publication Date
Jan 12, 2022